Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | prolyl endopeptidase | 0.0145 | 1 | 0.5 |
Toxoplasma gondii | prolyl endopeptidase | 0.0145 | 1 | 0.5 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0145 | 1 | 0.5 |
Trypanosoma cruzi | prolyl endopeptidase | 0.0145 | 1 | 1 |
Echinococcus multilocularis | prolyl endopeptidase | 0.0145 | 1 | 0.5 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0145 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable protease II PtrBa [first part] (oligopeptidase B) | 0.013 | 0.8259 | 1 |
Trypanosoma brucei | prolyl endopeptidase | 0.0145 | 1 | 1 |
Mycobacterium ulcerans | protease II (oligopeptidase B), PtrB | 0.0058 | 0 | 0.5 |
Onchocerca volvulus | Prolyl endopeptidase homolog | 0.0145 | 1 | 0.5 |
Leishmania major | prolyl oligopeptidase, putative,serine peptidase clan SC, family S9A, putative | 0.0145 | 1 | 1 |
Mycobacterium leprae | PROBABLE PROTEASE II PTRBB (OLIGOPEPTIDASE B) | 0.0058 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0145 | 1 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.